'JEB'--a carboplatin based regimen for malignant germ cell tumours in children.

Between February 1986 and July 1988 a total of 21 children aged 1 to 16 years with malignant germ cell tumours (MGCT), 18 with either metastatic disease or unresectable primary tumour, received the JEB regimen - carboplatin dosage calculated from the EDTA glomerular filtration rate (approximately 60...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinkerton, C. R., Broadbent, V., Horwich, A., Levitt, J., McElwain, T. J., Meller, S. T., Mott, M., Oakhill, A., Pritchard, J.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1990
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971831/
https://www.ncbi.nlm.nih.gov/pubmed/1696831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1971831/
https://www.ncbi.nlm.nih.gov/pubmed/1696831

Ejemplares similares